Thérapie, 59 1 (2004) 105-112

Article's citations

Article cité par

La fonctionnalité Article cité par… liste les citations d'un article. Ces citations proviennent de la base de données des articles de EDP Sciences, ainsi que des bases de données d'autres éditeurs participant au programme CrossRef Cited-by Linking Program. Vous pouvez définir une alerte courriel pour être prévenu de la parution d'un nouvel article citant " cet article (voir sur la page du résumé de l'article le menu à droite).

Article cité :

Les syndromes parkinsoniens médicamenteux

Nhan Nguyen, Vincent Pradel, Joëlle Micallef, Jean-Louis Montastruc, Olivier Blin

Thérapie, 59 1 (2004) 105-112

Publié en ligne : 2007-03-01

DOI: https://doi.org/10.2515/therapie:2004021

PDF (189.2 KB)

Citations de cet article :

White Matter Microstructure Alteration in Patients with Drug-Induced Parkinsonism: A Diffusion Tensor Imaging Study with Tract-Based Spatial Statistics

Ling Sun, Shijia He, Bo Cheng, Yao Shen, Wenhao Zhao, Rong Tu and Shushan Zhang
Journal of Integrative Neuroscience 23 (11) (2024)
https://doi.org/10.31083/j.jin2311202

Abderrezak KHELFI, I Djemili, Marie-Martin Bellouard, Abderrazek HEDHILI, Mohammed NEBBALI, Hasnae Hoummani, Omar Smaoui, Sanae ACHOUR, Nicolas Fabresse, Patrick Nisse, Aza Nawel KERROUCHI, Georges Brousse, Mohamed Anouar NOUIOUI, Céline Eiden, Mouni Herireche, Anne-Sophie LEMAIRE-HURTEL, Meriem Laribi, Philippe Leveau, François Darrouzain, Nadia Chaouali, Yoann Cazaubon, Oumaima Maalem, Mahdia OUGRINE, Bilel Moslah, M Aroud, et al.
687 (2023)
https://doi.org/10.1016/B978-2-294-77821-6.00009-0

Syndromes extrapyramidaux induits par les médicaments

E. Maeker and B. Maeker-Poquet
NPG Neurologie - Psychiatrie - Gériatrie 22 (127) 25 (2022)
https://doi.org/10.1016/j.npg.2021.05.006

Drug-induced parkinsonism: Revisiting the epidemiology using the WHO pharmacovigilance database

Sibylle de Germay, François Montastruc, Alfonso Carvajal, Maryse Lapeyre-Mestre and Jean-Louis Montastruc
Parkinsonism & Related Disorders 70 55 (2020)
https://doi.org/10.1016/j.parkreldis.2019.12.011

Tamoxifen and the risk of Parkinsonism: a case/non-case study

François Montastruc, Farzin Khosrow-Khavar, Sibylle de Germay, et al.
European Journal of Clinical Pharmacology 74 (9) 1181 (2018)
https://doi.org/10.1007/s00228-018-2496-3

A Case Report of Drug-Induced Parkinsonism Treated with Jodeung-san and Electro-acupuncture at GB34

Eun-ji Kim, Ho-joon Song, Hyun-ho Kim, Yang-hee Han and Jung-tae Leem
The Journal of Internal Korean Medicine 38 (5) 600 (2017)
https://doi.org/10.22246/jikm.2017.38.5.600

Thrombose veineuse cérébrale chez un patient parkinsonien : à propos d’un cas rare et trompeur survenu sous faibles doses de clozapine

Olivier Colin, Alexandre Quillet, Isabelle Benatru, et al.
Therapies 71 (5) 521 (2016)
https://doi.org/10.1016/j.therap.2016.02.030

Lithium Use in Older Adults is Associated with Increased Prescribing of Parkinson Medications

Connie Marras, Nathan Herrmann, Hadas D. Fischer, et al.
The American Journal of Geriatric Psychiatry 24 (4) 301 (2016)
https://doi.org/10.1016/j.jagp.2015.11.004

Suivi thérapeutique de l’acide valproïque chez l’enfant : étude prospective de l’effet de l’observance et du niveau économique sur les concentrations plasmatiques résiduelles et les crises épileptiques

Rim Charfi, Mohamed Lakhal, Anis Klouz, Sameh Trabelsi and Issam Salouage
Therapies 70 (5) 415 (2015)
https://doi.org/10.2515/therapie/2015024

Herbal Medicine Treatment for Drug-Induced Parkinsonism

Young-Ho Shim, Joo-Young Park, Won-Woo Choi, et al.
The Journal of Alternative and Complementary Medicine 21 (5) 273 (2015)
https://doi.org/10.1089/acm.2014.0124

Santiago Perez-Lloret, Jean-Louis Montastruc and Olivier Rascol
87 (2014)
https://doi.org/10.1007/978-1-4471-6365-7_6

Utilidad de la tomografía por emisión de fotón simple con 123Ioflupano en el diagnóstico del parkinsonismo relacionado con fármacos. Estudio prospectivo

J. Olivares Romero and A. Arjona Padillo
Neurología 28 (5) 276 (2013)
https://doi.org/10.1016/j.nrl.2012.05.005

Diagnostic accuracy of 123I-FP-CIT SPECT in diagnosing drug-induced parkinsonism: A prospective study

J. Olivares Romero and A. Arjona Padillo
Neurología (English Edition) 28 (5) 276 (2013)
https://doi.org/10.1016/j.nrleng.2012.05.007

Utility of transcranial sonography in the diagnosis of drug‐induced parkinsonism: a prospective study

J. Olivares Romero, A. Arjona Padillo, F. J. Barrero Hernández, M. Martín González and B. Gil Extremera
European Journal of Neurology 20 (11) 1451 (2013)
https://doi.org/10.1111/ene.12131

The role of striatal dopamine D2 receptors in the occurrence of extrapyramidal side effects: Iodine-123-iodobenzamide single photon emission computed tomography study

Iluminada Corripio, Alcides Ferreira, Maria J. Portella, et al.
Psychiatry Research: Neuroimaging 201 (1) 73 (2012)
https://doi.org/10.1016/j.pscychresns.2011.02.004

Drug-Induced Parkinsonism in the Elderly

José Luis López-Sendón, María Angeles Mena and Justo García de Yébenes
Drugs & Aging 29 (2) 105 (2012)
https://doi.org/10.2165/11598540-000000000-00000

Diagnostic Challenges Revealed from a Neuropsychiatry Movement Disorders Clinic

Heather Rigby, Angela Roberts-South, Hrishikesh Kumar, Leonardo Cortese and Mandar Jog
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques 39 (6) 782 (2012)
https://doi.org/10.1017/S0317167100015614

Syndromes parkinsoniens et mouvements involontaires médicamenteux dans la population âgée

A. -M. Bonnet, F. Cormier and L. Lacomblez
Les cahiers de l'année gérontologique 4 (2) 43 (2012)
https://doi.org/10.1007/s12612-012-0264-z

The Biochemical and Cellular Basis for Nutraceutical Strategies to Attenuate Neurodegeneration in Parkinson’s Disease

Elizabeth A. Mazzio, Fran Close and Karam F.A. Soliman
International Journal of Molecular Sciences 12 (1) 506 (2011)
https://doi.org/10.3390/ijms12010506

Drug‐induced parkinsonism: A review of 17 years' experience in a regional pharmacovigilance center in France

Emmanuelle Bondon‐Guitton, Santiago Perez‐Lloret, Haleh Bagheri, Christine Brefel, Olivier Rascol and Jean‐Louis Montastruc
Movement Disorders 26 (12) 2226 (2011)
https://doi.org/10.1002/mds.23828

Santiago Perez-Lloret and Marcelo Merello
139 (2011)
https://doi.org/10.1017/CBO9780511977749.014

Effetti indesiderati neurologici di origine farmacologica

E. Guitton, G. Durrieu and H. Bagheri
EMC - AKOS - Trattato di Medicina 13 (1) 1 (2011)
https://doi.org/10.1016/S1634-7358(11)70563-0

Dépendance et syndromes Parkinsoniens en gériatrie

O. Flabeau and I. Bourdel-Marchasson
Les cahiers de l'année gérontologique 3 (S1) 76 (2011)
https://doi.org/10.1007/s12612-011-0210-5

Prevalence of Parkinsonism in Older Patients with Hip Fracture

Konstantina G. Yiannopoulou, Sokratis G. Papageorgiou, Ioannis P. Anastasiou, Theodore K. Ganetsos and Kleanthis D. Karydakis
HIP International 21 (3) 351 (2011)
https://doi.org/10.5301/hip.2011.8402

Effets indésirables neurologiques d'origine médicamenteuse

E. Guitton, G. Durrieu and H. Bagheri
EMC - Traité de médecine AKOS 5 (3) 1 (2010)
https://doi.org/10.1016/S1634-6939(10)52305-6

Efectos secundarios neurológicos de origen farmacológico

E. Guitton, G. Durrieu and H. Bagheri
EMC - Tratado de Medicina 14 (4) 1 (2010)
https://doi.org/10.1016/S1636-5410(10)70493-1

Lithium: Updated Human Knowledge Using an Evidence-Based Approach

Etienne Marc Grandjean and Jean-Michel Aubry
CNS Drugs 23 (5) 397 (2009)
https://doi.org/10.2165/00023210-200923050-00004

Drug induced parkinsonism: a common cause of parkinsonism in older people

B Thanvi and S Treadwell
Postgraduate Medical Journal 85 (1004) 322 (2009)
https://doi.org/10.1136/pgmj.2008.073312

Postural induced‐tremor in psychiatry

Beatriz Arbaizar, Inés Gómez‐Acebo and Javier Llorca
Psychiatry and Clinical Neurosciences 62 (6) 638 (2008)
https://doi.org/10.1111/j.1440-1819.2008.01877.x

LOSS OF AUTONOMY RELATED TO VALPROIC ACID INTAKE

Marie Line Gaubert, Anne Cougnaud, Alaa Ghali, Corinne Bruhat, Bertrand Diquet and Gilles Berrut
Journal of the American Geriatrics Society 54 (12) 1971 (2006)
https://doi.org/10.1111/j.1532-5415.2006.00991.x

Sertraline, escitalopram and tianeptine related abnormal movements but not with bupropion: A case report

Elvan Ozalp, Haldun Soygur, Eylem S. Cankurtaran, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry 30 (7) 1337 (2006)
https://doi.org/10.1016/j.pnpbp.2006.03.002

Médicaments, maladie de Parkinson et syndromes parkinsoniens : actualités de pharmacovigilance**Ce travail a été présenté au 9e congrès de la Société Française de Pharmacologie / XXVIes Journées françaises de pharmacovigilance, Bordeaux, 26-28 avril 2005.

Jean-Louis Montastruc, Agnès Sommet, Pascale Olivier, et al.
Thérapie 61 (1) 29 (2006)
https://doi.org/10.2515/therapie:2006011

Syndrome parkinsonien médicamenteux : à propos d'un cas chez une patiente de 77 ans

J. Arzur, B. De la Gastine, A. Bessodes and A. Coquerel
La Revue de Médecine Interne 27 (5) 422 (2006)
https://doi.org/10.1016/j.revmed.2005.11.013

La trimétazidine – nouvelle étiologie de troubles extrapyramidaux : un cas de syndrome parkinsonien avec akathisie

Kamel Masmoudi, Valérie Gras-Champel, Youssef Douadi, Henri Masson and Michel Andréjak
Thérapie 60 (6) 603 (2005)
https://doi.org/10.2515/therapie:2005090